Cite
HARVARD Citation
Sakaki, A. et al. (2022). Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome. Leukemia & lymphoma. 63 (10), pp. 2499-2502. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sakaki, A. et al. (2022). Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome. Leukemia & lymphoma. 63 (10), pp. 2499-2502. [Online].